Download Full Text (641 KB)


Alzheimer's disease is characterized by the buildup of amyloid-beta (AB) protein in the brain, which disrupts brain function and leads to cognitive decline. Current research focuses on finding ways to reduce AB plaques.

Withaferin A, a compound found in Ashwagandha, a medicinal herb, shows promise as a potential treatment for Alzheimer's disease. Studies suggest Withaferin A may target AB, potentially by mechanisms beyond its interaction with acetylcholinesterase. Acetylcholinesterase is an enzyme that breaks down acetylcholine, a neurotransmitter important for memory and learning, but it's not the sole focus of current AB-targeting therapies.

Publication Date



Higher Education | Scholarship of Teaching and Learning

Withaferin A and Alzheimer's Disease: A Review



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.